We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$31.9B
AUM Growth
+$3.19B
Cap. Flow
+$655M
Cap. Flow %
2.06%
Top 10 Hldgs %
37.2%
Holding
1,711
New
132
Increased
1,102
Reduced
353
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 36.43%
2 Communication Services 10.67%
3 Consumer Discretionary 9.33%
4 Healthcare 6.07%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTT
1476
High Templar Tech Ltd
HTT
$391M
$23.2K ﹤0.01%
+5,433
New +$21.8K
HPP
1477
Hudson Pacific Properties
HPP
$777M
$22.9K ﹤0.01%
+1,187
New +$22.4K
MRAM icon
1478
Everspin Technologies
MRAM
$415M
$22.4K ﹤0.01%
+2,408
New +$16.4K
PSNL icon
1479
Personalis
PSNL
$1.52B
$22.4K ﹤0.01%
3,428
+16
+0.5% +$91
PCTY icon
1480
Paylocity
PCTY
$7.73B
$22.1K ﹤0.01%
139
+1
+0.7% +$177
TTEK icon
1481
Tetra Tech
TTEK
$9.09B
$22.1K ﹤0.01%
661
+1
+0.2% +$36
AAT
1482
American Assets Trust
AAT
$1.39B
$21.8K ﹤0.01%
1,072
+59
+6% +$1.19K
CSR
1483
Centerspace
CSR
$925M
$21.6K ﹤0.01%
366
+20
+6% +$1.16K
DEA
1484
Easterly Government Properties
DEA
$1.16B
$21.4K ﹤0.01%
935
+85
+10% +$1.93K
CRVS icon
1485
Corvus Pharmaceuticals
CRVS
$1.27B
$21.2K ﹤0.01%
2,881
-98
-3% -$502
TDC icon
1486
Teradata
TDC
$2.49B
$21K ﹤0.01%
975
-25
-3% -$538
ESPR
1487
DELISTED
Esperion Therapeutics
ESPR
$20.7K ﹤0.01%
7,795
+139
+2% +$269
ZVRA icon
1488
Zevra Therapeutics
ZVRA
$679M
$20.6K ﹤0.01%
2,170
+58
+3% +$582
CMPS
1489
Compass Pathways
CMPS
$1.97B
$20.3K ﹤0.01%
3,546
+32
+0.9% +$144
PRTA icon
1490
Prothena Corp
PRTA
$475M
$20.3K ﹤0.01%
2,081
+2
+0.1% +$15
RIOT icon
1491
Riot Platforms
RIOT
$7.63B
$20.2K ﹤0.01%
1,062
-67
-6% -$928
NVST icon
1492
Envista
NVST
$4.61B
$20.1K ﹤0.01%
989
-512
-34% -$10.5K
SAIA icon
1493
Saia
SAIA
$9.73B
$20.1K ﹤0.01%
67
PLYM
1494
DELISTED
Plymouth Industrial REIT
PLYM
$20.1K ﹤0.01%
898
+49
+6% +$900
COLM icon
1495
Columbia Sportswear
COLM
$2.88B
$20K ﹤0.01%
382
-83
-18% -$4.67K
LBRDK icon
1496
Liberty Broadband Class C
LBRDK
$5.07B
$20K ﹤0.01%
314
+6
+2% +$419
RIGL icon
1497
Rigel Pharmaceuticals
RIGL
$782M
$19.6K ﹤0.01%
693
+3
+0.4% +$90
ARCT icon
1498
Arcturus Therapeutics
ARCT
$216M
$19.4K ﹤0.01%
1,050
+2
+0.2% +$32
IRBT
1499
DELISTED
iRobot
IRBT
$19.3K ﹤0.01%
5,379
+125
+2% +$483
LKFT
1500
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$19.2K ﹤0.01%
554
-18
-3% -$576

Similar funds

Mirae Asset Global Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Mirae Asset Global Investments held 1,711 positions worth $31.9B, up 11% from $28.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mirae Asset Global Investments's Q3 2025 filing shows 132 new, 1,102 increased, 353 reduced and 69 closed positions. Its largest new stake was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M. The largest sale was Vanguard S&P 500 ETF, an estimated $453M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Mirae Asset Global Investments's largest Q3 2025 buy was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M.
  • Mirae Asset Global Investments added most to NVIDIA in Q3 2025, an estimated $81.9M increase.
  • Mirae Asset Global Investments's biggest Q3 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $453M.
  • Mirae Asset Global Investments fully exited iShares S&P 100 ETF in Q3 2025, selling an estimated $58.9M.
  • Mirae Asset Global Investments's ten largest holdings make up 37% of its $31.9B portfolio in Q3 2025.
  • Mirae Asset Global Investments opened 132 new positions and closed 69 in Q3 2025.
  • Mirae Asset Global Investments's portfolio value rose 11% quarter-over-quarter to $31.9B.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.